Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

The Department of Health – Abu Dhabi (DoH) and Sanofi have signed a memorandum of understanding (MoU) to bolster vaccine ...

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

NextCure has entered a strategic partnership with Simcere Zaiming, to develop SIM0505, a new ADC targeting CDH6 for treating ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and ...

Questions remain as to how FDA inspection differences between domestic and foreign drug facilities will play out.

The NSW government has announced an investment of A$20.7m ($13.39m) aimed at providing access to life-changing therapies.

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

While the outlook for vaccines in the US looks bleak under Trump's administration, the UK is pressing ahead with securing its ...

Actio Biosciences has closed a Series B financing round, raising $66m for advancing the genetics-driven small molecule ...